1. Home
  2. STAA vs ELVN Comparison

STAA vs ELVN Comparison

Compare STAA & ELVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STAA
  • ELVN
  • Stock Information
  • Founded
  • STAA 1982
  • ELVN 2016
  • Country
  • STAA United States
  • ELVN United States
  • Employees
  • STAA N/A
  • ELVN N/A
  • Industry
  • STAA Ophthalmic Goods
  • ELVN Biotechnology: Pharmaceutical Preparations
  • Sector
  • STAA Health Care
  • ELVN Health Care
  • Exchange
  • STAA Nasdaq
  • ELVN Nasdaq
  • Market Cap
  • STAA 1.2B
  • ELVN 1.0B
  • IPO Year
  • STAA N/A
  • ELVN 2020
  • Fundamental
  • Price
  • STAA $23.49
  • ELVN $21.60
  • Analyst Decision
  • STAA Buy
  • ELVN Strong Buy
  • Analyst Count
  • STAA 7
  • ELVN 5
  • Target Price
  • STAA $42.83
  • ELVN $37.80
  • AVG Volume (30 Days)
  • STAA 701.0K
  • ELVN 269.1K
  • Earning Date
  • STAA 02-19-2025
  • ELVN 03-13-2025
  • Dividend Yield
  • STAA N/A
  • ELVN N/A
  • EPS Growth
  • STAA 9.97
  • ELVN N/A
  • EPS
  • STAA 0.44
  • ELVN N/A
  • Revenue
  • STAA $341,224,000.00
  • ELVN N/A
  • Revenue This Year
  • STAA $8.37
  • ELVN N/A
  • Revenue Next Year
  • STAA $10.55
  • ELVN N/A
  • P/E Ratio
  • STAA $52.79
  • ELVN N/A
  • Revenue Growth
  • STAA 10.01
  • ELVN N/A
  • 52 Week Low
  • STAA $21.13
  • ELVN $10.90
  • 52 Week High
  • STAA $52.68
  • ELVN $30.03
  • Technical
  • Relative Strength Index (RSI)
  • STAA 44.66
  • ELVN 47.03
  • Support Level
  • STAA $22.49
  • ELVN $20.40
  • Resistance Level
  • STAA $24.50
  • ELVN $22.42
  • Average True Range (ATR)
  • STAA 0.96
  • ELVN 1.25
  • MACD
  • STAA 0.15
  • ELVN 0.06
  • Stochastic Oscillator
  • STAA 50.24
  • ELVN 59.59

About STAA STAAR Surgical Company

Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company also makes lenses that are used in surgery to treat cataracts. The company offers two types of products: Implantable Collamer lenses (ICL) and intraocular lens (IOL). The ICLs are used in refractive surgery and IOLs are used in cataract surgery. The majority of sales are generated from the ophthalmic surgical product segment.

About ELVN Enliven Therapeutics Inc.

Enliven Therapeutics Inc is a clinical-stage precision oncology company focused on the discovery and development of potentially first-in-class precision oncology therapies. Enliven's programs are designed to address issues such as tolerability, combinability, resistance and disease escape through brain metastases. Its product candidates include ELVN-001 which is a potent, selective, small molecule kinase inhibitor designed to specifically target the BCR-ABL gene fusion, the oncogenic driver for patients with chronic myeloid leukemia, and the ELVN-002 which is central nervous system (CNS) penetrant and irreversible HER2 inhibitor with activity against wild type HER2 and various HER2 mutations.

Share on Social Networks: